• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care
    Get the next $SYK alert in real time by email

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care

    PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans.

    Triathlon Gold

    Triathlon Gold: Building on the legacy and trusted performance1 of the Triathlon system, Triathlon Gold is Stryker's first commercially available femoral component, designed as an option for patients with metal sensitivity concerns. Using additive manufacturing, also known as 3D printing, it features a Titanium nitride surface and Triathlon cementless technology designed to deliver fixation2 and long-term durability3 with scratch resistance superior to competitive surfaces4, and the flexibility for both cemented and cementless workflows.

    Triathlon Medial Stabilized (MS) Insert: Another advancement in the Triathlon Total Knee System, the MS Insert allows customers to leverage the advantages of Mako SmartRobotics™ and Triathlon Cementless technologies, now with your preferred tibial insert. The MS Insert is designed to provide enhanced stability5-7 for Triathlon primary knee patients, while allowing more natural rotational kinematics.8

    "With more than 20 years of proven outcomes, the Triathlon system has set a high standard in knee replacement," said Lisa Kloes, vice president and general manager of Stryker's Knee business. "Triathlon Gold and the Triathlon Medial Stabilized (MS) Insert represent the next evolution of that legacy -- solutions shaped by customer insight and designed to meet the evolving needs of patients."

    Mako Shoulder: Now in full market release, Mako Shoulder is designed to transform primary reverse shoulder surgery by simplifying complex clinical tasks, giving surgeons confidence in executing their procedure to plan. The platform integrates Tornier Perform Reversed shoulder implants, Blueprint planning software and Mako SmartRobotics™ to deliver a comprehensive, connected solution. Mako Shoulder will also be available on Mako 4 in the second half of 2026.

    Mako RPS: Previously announced, the newest addition to join the Mako family is Mako RPS (Robotic Power System) for Total Knee. Compatible with Stryker's Triathlon Total Knee System, Mako RPS is a handheld robotic system that combines Stryker's proven robotics and power tool legacies and represents Mako's solution for a subset of surgeons looking for the familiarity of a manual power tool while leveraging the advantages of enabling technology.

    BPX™ and TPX® HD: New introductions to the power tools portfolio include the BPX cordless micro power tool system for extremities procedures and TPX HD, a comprehensive solution built for the needs of total joint revisions, trauma and minimally invasive foot and ankle surgeries with enhanced power, customizable control, and specialized attachments capable of cutting through metal and bone cement. These launches are complemented by the 7900 Attachments, the next generation of surgical attachments, representing an advancement in attachment design.

    "As the industry continues to evolve, Stryker is expanding our capabilities across orthopaedic specialties," said Katherine Truppi, president of Stryker's Joint Replacement division. "Surgeons and patients are seeking more solutions, and these innovations are designed to do just that -- helping patients get back to the activities they love."

    Attendees of the AAOS 2026 Annual Meeting can visit Stryker's booth (#3339) to learn more about these products, among others. Stryker will hold demonstrations, exhibitions and several symposiums throughout the week.

    About Stryker

    Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

    Media contact

    Stryker, Joint Replacement

    Niamh Grano

    Sr. Communications Manager

    [email protected] 

    References

    1. Nam, D., Lawrie, C. M., Salih, R., Nahhas, C. R., Barrack, R. L., & Nunley, R. M. (2019). Cemented Versus Cementless Total Knee Arthroplasty of the Same Modern Design. The Journal of Bone and Joint Survery, 101(13), 1185-1192. doi:10.2106/jbjs.18.01162
    2. Stryker Test Report: D0000325745 Triathlon Gold Micromotion Verification Testing. July, 2025.
    3. Stryker Test Report: D0000321183. Triathlon Gold CR Femoral Component: Posterior Femoral Fatigue Verification Testing. September, 2025.
    4. Stryker Test Report: D0000394012. Comparative Evaluation of Scratch Resistance in Total Knee Femoral Implants: Triathlon Gold (TiN-coated Ti6AL4V) vs. Oxinium Legion (Oxidized Zr-2.5Nb). September, 2025.
    5. D0000373518. Virtual Range of Constraint Measurement of Triathlon Medial Stabilized Insert Family in Extension.
    6. D0000361177. Virtual Range of Constraint Measurement of Triathlon Medial Stabilized Insert Family in Active Flexion.
    7. D0000373525. Virtual Range of Constraint Measurement of Triathlon Medial Stabilized Insert Family in Deep Flexion.
    8. D0000367859. Knee Kinematic Model (KKM) Library Verification of the Medial Stabilized Insert

    JR-GSNPS-PRESS-3062400

    Triathlon Medial Stabilized (MS) Insert

    Mako RPS (Robotic Power System)

    Stryker Logo Black text

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/stryker-showcases-continued-innovation-across-orthopaedics-at-aaos-2026-annual-meeting-302701824.html

    SOURCE Stryker

    Get the next $SYK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYK

    DatePrice TargetRatingAnalyst
    2/20/2026Outperform
    William Blair
    1/27/2026$387.00Hold
    TD Cowen
    1/6/2026$418.00Mkt Perform → Outperform
    Raymond James
    12/19/2025$440.00Mkt Perform → Mkt Outperform
    Citizens JMP
    9/18/2025$420.00Neutral
    Rothschild & Co Redburn
    2/26/2025$450.00Buy
    Citigroup
    12/2/2024$370.00 → $445.00Equal-Weight → Overweight
    Morgan Stanley
    9/10/2024$405.00Outperform
    Wolfe Research
    More analyst ratings

    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Stryker

    William Blair initiated coverage of Stryker with a rating of Outperform

    2/20/26 8:25:36 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    TD Cowen resumed coverage on Stryker with a new price target

    TD Cowen resumed coverage of Stryker with a rating of Hold and set a new price target of $387.00

    1/27/26 8:50:06 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker upgraded by Raymond James with a new price target

    Raymond James upgraded Stryker from Mkt Perform to Outperform and set a new price target of $418.00

    1/6/26 8:28:26 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stryker Ronda E gifted 55,600 shares (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    2/24/26 4:13:09 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Director Stryker Ronda E gifted 600,200 shares and disposed of 42,000 shares (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    2/18/26 5:44:50 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Director Stryker Ronda E sold $181,719,269 worth of shares (500,000 units at $363.44) (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    2/6/26 6:21:06 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    SEC Filings

    View All

    SEC Form 10-K filed by Stryker Corporation

    10-K - STRYKER CORP (0000310764) (Filer)

    2/11/26 11:43:02 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - STRYKER CORP (0000310764) (Filer)

    1/29/26 4:11:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - STRYKER CORP (0000310764) (Filer)

    12/4/25 4:16:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation

    Elevating care with Stryker's next generation device, Synchfix EVT, which will be featured at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual MeetingPORTAGE, Mich., Feb. 24, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of Synchfix™ EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions. Commonly associated with sports trauma and ankle fractures, ankle syndesmotic injuries can si

    2/24/26 8:41:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker launches T2 Alpha Humerus Nailing System, supporting surgical workflow and care for complex fractures

    PORTAGE, Mich., Feb. 11, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of the T2 Alpha Humerus Nailing System, the latest addition to its T2 Alpha portfolio. The system offers surgeons a streamlined approach to humeral fracture fixation while providing hospital teams with a unified platform that enables consistent, high-quality care.  Designed using Stryker's SOMA (Stryker Orthopaedic Modeling and Analytics) technology, the T2 Alpha Humerus Nailing System helps manage complex humerus fractures, including non-unions, malu

    2/11/26 9:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    3/11/25 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Kadant Set to Join S&P SmallCap 600

    NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE:KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE:SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name      Action Company Name Ticker GICS Sector February 19, 2025 S&P SmallCap 600 Addition Kadant KAI Industrials February 19, 2025 S&P SmallCap 600 Deletion Inari Medical NARI Health Care For more information about

    2/13/25 5:54:00 PM ET
    $KAI
    $NARI
    $SPGI
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    $SYK
    Financials

    Live finance-specific insights

    View All

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 15

    2/4/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports 2025 operating results and 2026 outlook

    Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        17.5        %         0.9        %         16.6        %         4.0        %         12.6        %

    1/29/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker

    Deal expands global manufacturing footprint and positions VB Spine for future growth in spine care VB Spine LLC ("VB Spine") today completed the acquisition of Stryker's spine implant manufacturing facility in Cestas, France. Known for its state-of-the-art operations and technical capabilities, the Cestas facility will play a central role in VB Spine's global manufacturing strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106463289/en/VB Spine's manufacturing facility in Cestas, France This milestone expands on the April 1, 2025 formation of VB Spine, established through the acquisition of Stryker's U.S. spine implan

    1/6/26 8:57:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/14/23 12:37:55 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/10/23 9:18:16 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care